GO
Loading...
 
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Regeneron beats estimates; seeks early FDA approval of Eylea

Tue 06 Aug 13 | 10:15 AM ET
Leonard Schleifer, Regeneron Pharmaceuticals president and CEO, breaks down the company's better-than-expected earnings, and positive results from its phase three trials of a drug designed to improve vision in patients with diabetic macular edema.
 
RELATED ARTICLES AND CONTENT
More Videos
  • No Articles Available
Latest Videos
Boh Plantations: Why being Malaysian matters to us
Sun 20 Apr 14 | 09:42 PM ET
Latest Videos
GM: 'Huge opportunity' for Cadillac in China
Sun 20 Apr 14 | 09:34 PM ET
Latest Videos
Beijing to become third gold import point for China
Sun 20 Apr 14 | 08:53 PM ET
Latest Videos
US dollar to see gains this week: Maybank
Sun 20 Apr 14 | 08:32 PM ET
Go
Displaying results for: Latest Video | US